ALK+ ALCL is characterized, in most cases, by the t(2;5)(p23;q35) chromosomal translocation involving the nucleophosmin (NPM) and the ALK gene, resulting in the expression and constitutive activation of chimeric ALK fusion protein. The gene discussed is ALK; the disease is anaplastic large cell lymphoma.